Eleva Capital’s Fennec Pharmaceuticals FENC Stock Holding History

Eleva Capital’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-53,234	Closed	-$327K	–	34
2026 Q2	$327K	Hold	53,234	–	–	0.1%	18
2026 Q1	$327K	Buy	+53,234	New	+$411K	0.1%	18

Other funds holding FENC

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Eleva Capital's FENC Position: Q3 2026 in Review

Eleva Capital sold out of Fennec Pharmaceuticals (FENC) in Q3 2026, closing a stake of 53,234 shares — an estimated $327K sold.

Eleva Capital first reported a position in FENC in Q1 2026 and held it in 2 quarters. The position peaked at $327K in Q2 2026. 1 fund tracked by Wall St. Rank holds FENC as of Q3 2026.

Eleva Capital reported no remaining Fennec Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
Eleva Capital sold 53,234 Fennec Pharmaceuticals shares in Q3 2026, an estimated $327K.
Eleva Capital first reported a position in Fennec Pharmaceuticals in Q1 2026 and held it in 2 quarters.
Eleva Capital's Fennec Pharmaceuticals position peaked at $327K in Q2 2026.
1 fund tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.